Position in ZVRA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,473,600
-$625,428 QoQ
Shares Held
480,000
-15.7% QoQ
Ownership
0.812%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stonepine Capital Management, LLC holds $317,990,358 across 56 Biotechnology names. ZVRA ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RADX |
Radiopharm Theranostics Ltd
|
51,000,000 | $219,300,000 | |
| 2 | VSTM |
Verastem, Inc.
|
3,302,300 | $17,502,190 | |
| 3 | TENX |
Tenax Therapeutics, Inc.
|
975,200 | $15,593,448 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
740,000 | $6,667,400 | |
| 5 | CAMP |
Camp4 Therapeutics Corp
|
1,389,622 | $6,128,233 | |
| 6 | NKTR |
Nektar Therapeutics
|
85,000 | $6,115,750 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
480,000 | $4,473,600 | |
| 8 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
383,462 | $3,600,708 |
All Filings in ZVRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,473,600 | 480,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,099,028 | 569,088 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,703,100 | 810,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,833,212 | 775,620 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,868,500 | 650,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,984,818 | 597,700 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,858,000 | 700,000 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||